Y Oishi1, Z W Fu, Y Ohnuki, H Kato, T Noguchi. 1. Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, Tokyo University, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan.
Abstract
BACKGROUND: Glucocorticoids are widely used for the treatment of various diseases, despite known side-effects such as skin atrophy. Many studies have shown that the status of collagen fibres in the skin is affected by glucocorticoid treatment. However, the molecular mechanism underlying the alteration of collagen metabolism in the skin by glucocorticoid treatment remains unknown. OBJECTIVES: To characterize the molecular mechanisms related to the deterioration of the dermis in response to glucocorticoids, the status of two major types of collagen, collagenase, and tissue inhibitors of metalloproteinases (TIMPs) in the dorsal skin of rats was studied at the protein and mRNA levels. METHODS: Samples of rat dorsal skin were obtained after daily (1 mg kg-1) subcutaneous injections of dexamethasone (DEX) for 8 days. mRNA levels of two types of collagen and of TIMPs were measured by a lysate RNase protection assay. mRNA levels of collagenase were measured by a quantitative polymerase chain reaction. Protein levels of collagen and collagenase were measured by an immunoblot analysis. RESULTS: Levels of type I tropocollagen and type III tropocollagen were drastically reduced in response to DEX. The effects of DEX treatment were more severe on type III than type I collagen: it also produced a significant decrease in fibril collagen of type III collagen. DEX treatment was found to decrease both active and latent forms of collagenase as well as its mRNA levels. Among TIMPs, mRNA levels of TIMP-1 and TIMP-2 were decreased in response to DEX treatment, whereas those of TIMP-3 were not affected. CONCLUSIONS: These results suggest that DEX treatment strongly interferes with both the synthesis and degradation of type I collagen and, more drastically, type III collagen, the molecule that is known to play a major role in the initiation of wound healing. The present study may provide a molecular basis for the deterioration of skin function, impaired wound healing, and skin atrophy caused by glucocorticoid treatment.
BACKGROUND: Glucocorticoids are widely used for the treatment of various diseases, despite known side-effects such as skin atrophy. Many studies have shown that the status of collagen fibres in the skin is affected by glucocorticoid treatment. However, the molecular mechanism underlying the alteration of collagen metabolism in the skin by glucocorticoid treatment remains unknown. OBJECTIVES: To characterize the molecular mechanisms related to the deterioration of the dermis in response to glucocorticoids, the status of two major types of collagen, collagenase, and tissue inhibitors of metalloproteinases (TIMPs) in the dorsal skin of rats was studied at the protein and mRNA levels. METHODS: Samples of rat dorsal skin were obtained after daily (1 mg kg-1) subcutaneous injections of dexamethasone (DEX) for 8 days. mRNA levels of two types of collagen and of TIMPs were measured by a lysate RNase protection assay. mRNA levels of collagenase were measured by a quantitative polymerase chain reaction. Protein levels of collagen and collagenase were measured by an immunoblot analysis. RESULTS: Levels of type I tropocollagen and type III tropocollagen were drastically reduced in response to DEX. The effects of DEX treatment were more severe on type III than type I collagen: it also produced a significant decrease in fibril collagen of type III collagen. DEX treatment was found to decrease both active and latent forms of collagenase as well as its mRNA levels. Among TIMPs, mRNA levels of TIMP-1 and TIMP-2 were decreased in response to DEX treatment, whereas those of TIMP-3 were not affected. CONCLUSIONS: These results suggest that DEX treatment strongly interferes with both the synthesis and degradation of type I collagen and, more drastically, type III collagen, the molecule that is known to play a major role in the initiation of wound healing. The present study may provide a molecular basis for the deterioration of skin function, impaired wound healing, and skin atrophy caused by glucocorticoid treatment.
Authors: Jin-Ki Kim; Hong Yuan; Jingxin Nie; Yu-Tsai Yang; Markos Leggas; Philip M Potter; John Rinehart; Michael Jay; Xiuling Lu Journal: Small Date: 2012-07-06 Impact factor: 13.281
Authors: Katherine B Peters; Thomas E Coyle; James J Vredenburgh; Annick Desjardins; Henry S Friedman; David A Reardon Journal: J Neurooncol Date: 2010-06-04 Impact factor: 4.130
Authors: Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk Journal: J Orthop Res Date: 2015-03-08 Impact factor: 3.494
Authors: Becky K Brisson; Elizabeth A Mauldin; Weiwei Lei; Laurie K Vogel; Ashley M Power; Albert Lo; Derek Dopkin; Chand Khanna; Rebecca G Wells; Ellen Puré; Susan W Volk Journal: Am J Pathol Date: 2015-03-17 Impact factor: 4.307
Authors: Sukanya Narasimhan; Melissa J Caimano; Fang Ting Liang; Felix Santiago; Michelle Laskowski; Mario T Philipp; Andrew R Pachner; Justin D Radolf; Erol Fikrig; Melissa J Camaino Journal: Proc Natl Acad Sci U S A Date: 2003-12-11 Impact factor: 11.205
Authors: Ana Tiganescu; Abd A Tahrani; Stuart A Morgan; Marcela Otranto; Alexis Desmoulière; Lianne Abrahams; Zaki Hassan-Smith; Elizabeth A Walker; Elizabeth H Rabbitt; Mark S Cooper; Kurt Amrein; Gareth G Lavery; Paul M Stewart Journal: J Clin Invest Date: 2013-06-03 Impact factor: 14.808